Immunotechnology

Antibody phage display technology and its applications
pp. 1-20(20)
Authors: Hoogenboom H.R.; de Brune A.P.; Hufton S.E.; Hoet R.M.; Arends J.-W.; Roovers R.C.

Selection of phage displayed peptides from a random 10-mer library recognising a peptide target
pp. 21-28(8)
Authors: Bremnes T.; Lauvrak V.; Lindqvist B.; Bakke O.

Immunoglobulin G abnormalities in HIV-1 infected individuals with lymphoma
pp. 29-36(8)
Authors: Lundholm P.; Lucht E.; Svedmyr E.; Ruden U.; Linde A.; Wahren B.

Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies
pp. 37-47(11)
Authors: Paterson T.; Innes J.; McMillan L.; Downing I.; McCann Carter M.C.

Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs
pp. 49-57(9)
Authors: Hefta L.J.F.; Neumaier M.; Shively J.E.

Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs
pp. 59-69(11)
Authors: Hemminki A.; Niemi S.; Hautoniemi L.; Soderlund H.; Takkinen K.

Characterization of anti-mouse FcRII single-chain Fv fragments derived from human phage display libraries
pp. 71-87(17)
Authors: McCall A.M.; Amoroso A.R.; Sautes C.; Marks J.D.; Weiner L.M.